Can-Fite BioPharma CANF
NYSE CANF
$1.66 -0.02 (-1.19%)
As of: Nov 10, 2026 · 1:24 PM EST

Can-Fite BioPharma (CANF) EPS (Diluted) (2020 - 2023)

Updated

Can-Fite BioPharma (CANF) recorded EPS (Diluted) of -$11.94 in FY2025, compared with -$0.14 in FY2024.

Analysis

Can-Fite BioPharma (CANF) EPS (Diluted) (2020 - 2023) Analysis & Trends

Starting with FY2020, Can-Fite BioPharma's EPS (Diluted) history includes 6 years.

  • The FY2025 figure is the lowest annual EPS (Diluted) in data going back to FY2020.
  • Per Business Quant data, CANF's EPS (Diluted) was -$0.14 in FY2024, -$0.24 in FY2023, -$0.37 in FY2022 and -$0.73 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 7.22
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.09
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 2.38
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 2.04
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.67
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 1.60
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 7.08
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 1.94
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 0.56
10 Can-Fite BioPharma 1.36 Mn -18.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -0.05
Sep 30, 2023 -0.09
Jun 30, 2023 0.12
Mar 31, 2023 -0.13
Dec 31, 2022 -0.02
Sep 30, 2022 -0.18
Jun 30, 2022 0.18
Mar 31, 2022 -0.18
Dec 31, 2021 -0.30
Sep 30, 2021 -0.38
Jun 30, 2021 -0.36
Mar 31, 2021 -0.21
Dec 31, 2020 -0.41
API Access

Can-Fite BioPharma EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=CANF&period=max&api_key=YOUR_API_KEY